GB 3232-1982
Abolished
T/CMEAS 015-2023
Active
Group standards
T/CMEAS 015-2023 Individualized drug use gene testing and application guidelines
T/CMEAS 015-2023 Individualized drug use gene testing and application guidelines
Price:
$ 20.00
Basic Information
Standard Code:
T/CMEAS 015-2023
Standard Type:
Group standards
Standard Status:
Active
is_force_gb:
no
CCS Name:
-
ICS Name:
Integrated medical science and healthcare devices
Publish Date:
2023-11-28
Implement Date:
2023-11-28
Scope
Main technical content: This document specifies the basic requirements for laboratories in personalized drug gene detection and application, the process of personalized drug gene detection, and the requirements for report issuance and interpretation. This document is applicable to the detection of drug metabolism enzymes, transporters, and drug target sites. This document is not applicable to the detection of gene mutations in targeted cancer therapies and microbial genome mutations.
Development Information
Related Standards
GB 3233-1982
Abolished
GB 3233-1982 Diagnostic criteria and principles of management of occupational chronic carbon disulfide poisoning
GB 3234-1982
Abolished
GB 3234-1982 Diagnostic criteria and principles of management of industrial fluorosis
GB 4865-1985
Abolished
GB 4865-1985 Diagnostic criteria and principles of management of occupational chronic allyl chloride poisoning
GB 4869-1985
Abolished
GB 4869-1985 Diagnostic criteria and principles of management of occupational vibration disease
GB 5044-1985
Abolished